The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Elucidating the immune active state of HR+HER2- MammaPrint High 2 early breast cancer.
 
Erin Frances Cobain
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca/Daiichi Sankyo; Athenex; Ayala Pharmaceuticals; bioTheranostics; Immunomedics
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Lajos Pusztai
Honoraria - Athenex; bioTheranostics; natera; OncoCyte
Consulting or Advisory Role - Almac Diagnostics; AstraZeneca; Bristol Myers Squibb; Clovis Oncology; Eisai; H3 Biomedicine; Immunomedics; Merck; Novartis; Pfizer; Roche/Genentech; Seagen; Syndax
Research Funding - AstraZeneca (Inst); Bristol Myers Squibb (Inst); Genentech (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca
(OPTIONAL) Uncompensated Relationships - Foundation Medicine; NanoString Technologies
 
Cathy Lynne Graham
Consulting or Advisory Role - Agendia
Research Funding - Agendia
 
Pat W. Whitworth
Employment - Aptitude Health; Integra LifeSciences (I)
Leadership - Integra LifeSciences (I)
Stock and Other Ownership Interests - Aptitude Health; Integra LifeSciences (I)
Honoraria - Endomag
Consulting or Advisory Role - ImpediMed; Prelude Therapeutics
Research Funding - Agendia; Exact Sciences; Prelude Therapeutics
Travel, Accommodations, Expenses - Targeted Medical Education, Inc.
 
Peter D. Beitsch
Employment - InVitae
Leadership - Targeted Medical Education, Inc.
Stock and Other Ownership Interests - InVitae; Targeted Medical Education, Inc.
Honoraria - Castle Biosciences
Research Funding - InVitae
(OPTIONAL) Uncompensated Relationships - Medneon
 
Cynthia R. C. Osborne
Honoraria - Agendia; Breast Cancer Index; Guardant Health; Immunomedics; Seagen
Speakers' Bureau - Lilly; Novartis
Travel, Accommodations, Expenses - Lilly; Novartis
 
Rakhshanda Layeequr Rahman
Honoraria - MOLLI Surgical
 
Nathalie MCDOWELL Johnson
Research Funding - Agendia
 
Adam Brufsky
Consulting or Advisory Role - Agendia; Daiichi Sankyo/Lilly; Eisai; Genentech/Roche; General Electric; Gilead Sciences; Lilly; Merck; Michael J. Hennessy Associates; Myriad Pharmaceuticals; Novartis; Onc Live; Pfizer; Puma Biotechnology; Seagen
Research Funding - AstraZeneca/Daiichi Sankyo (Inst); Gilead Sciences (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst)
Expert Testimony - Pfizer
 
Reshma L. Mahtani
Consulting or Advisory Role - Agendia; Amgen; Daiichi Sankyo/Astra Zeneca; Eisai; Genentech/Roche; Gilead Sciences; Hologic/Biotheranostics; Lilly; Merck; Novartis; Pfizer; Puma Biotechnology; Sanofi; Sermonix Pharmaceuticals; Stemline Therapeutics
Speakers' Bureau - Seattle Genetics/Astellas
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Agendia; Amgen; AstraZeneca; bioTheranostics; Daiichi Sankyo/Lilly; Eisai; Genentech/Roche; Lilly; Merck; Novartis; Pfizer; Puma Biotechnology; Sanofi; Seagen
 
VK Gadi
Stock and Other Ownership Interests - 3rdEyeBio; Emerging Markets Cancer Ignition Fund; New Equilibrium Biosciences; Novilla; Phoenix Molecular Designs; Sengine precision medicine; Tahoma Therapeutics
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Hologic; Puma Biotechnology; Seagen/Pfizer; Stemline Therapeutics
Speakers' Bureau - Hologic; Puma Biotechnology; Seagen; Stemline Therapeutics
Research Funding - Agendia (Inst); Illumina; Tizona Therapeutics, Inc.
Travel, Accommodations, Expenses - Genentech/Roche; Puma Biotechnology; Seagen
 
Kent Hoskins
Employment - Lilly (I)
Research Funding - Abbvie (Inst); Genentech (Inst); Merck Sharp & Dohme (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Agendia
Other Relationship - Agendia
 
Hannah M. Linden
Leadership - Evolent (I); Progyny (I)
Stock and Other Ownership Interests - Evolent (I)
Consulting or Advisory Role - GE Healthcare; Gilead Sciences; Novartis; Pfizer; Sanofi
Research Funding - Pfizer (Inst); Sanofi/Aventis (Inst); Tolmar (Inst); Veru; Zeno Pharmaceuticals (Inst); Zionexa (Inst); Zymeworks (Inst)
 
Rita A. Mukhtar
Patents, Royalties, Other Intellectual Property - Patent on the use of fibrin and silver microparticles to promote wound healing. (I)
 
Laura Esserman
Consulting or Advisory Role - Blue Cross Blue Shield Association
Research Funding - Moderna Therapeutics (Inst)
Travel, Accommodations, Expenses - Blue Cross Blue Shield Association
(OPTIONAL) Uncompensated Relationships - Quantum Leap Healthcare Collaborative
 
Josien Haan
Employment - Agendia
 
Katie Quinn
Employment - Agendia
 
Andrea Menicucci
Employment - Agendia
 
M. William Audeh
Employment - Agendia
Leadership - Agendia
Stock and Other Ownership Interests - Agendia
Consulting or Advisory Role - Celanese; Private Health; Quantum Health
Research Funding - Agendia
Travel, Accommodations, Expenses - Agendia
 
Joyce O'Shaughnessy
Honoraria - Abbvie; Agendia; Amgen; Aptitude Health; AstraZeneca; BioNTech; Byondis; Carrick Therapeutics; Daiichi Sankyo; DAVA Oncology; Eisai; Fishawack Health; G1 Therapeutics; Genentech; Genzyme; Gilead Sciences; GlaxoSmithKline; Lilly; Loxo/Lilly; Merck; Novartis; Ontada/McKesson; Pfizer; Pierre Fabre; Puma Biotechnology; Roche; Samsung; Sanofi; Seagen; Stemline Therapeutics; Taiho Oncology; Veru
Consulting or Advisory Role - Abbvie; Agendia; Amgen; Aptitude Health; AstraZeneca; BioNTech; Byondis; Carrick Therapeutics; Daiichi Sankyo; DAVA Oncology; Eisai; Fishawack Health; G1 Therapeutics; Genentech; Genzyme; Gilead Sciences; GlaxoSmithKline; Lilly; Loxo/Lilly; Merck; Novartis; Ontada/McKesson; Pfizer; Pierre Fabre; Puma Biotechnology; Roche; Samsung; Sanofi; Seagen; Stemline Therapeutics; Taiho Oncology; Veru
Speakers' Bureau - AstraZeneca; Lilly; Novartis; Pfizer; Seagen
Travel, Accommodations, Expenses - Agendia; Aptitude Health; AstraZeneca; Daiichi Sankyo; DAVA Oncology; Eisai; Lilly; Loxo/Lilly; Merck; Novartis; Pfizer; Roche; Seagen